Acute Concussion and Melatonin

PHASE2RecruitingINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Concussion, MildConcussion, BrainPediatric ALL
Interventions
DRUG

Melatonin 3 MG

Participants in the melatonin group will be instructed to take 3-mg liquid melatonin pill 1 hour prior to their habitual fall asleep time daily for 30 days.

OTHER

Placebo

Participants in the placebo group will be instructed to take liquid placebo pill 1 hour prior to their habitual fall asleep time daily for 30 days.

Trial Locations (1)

20010

RECRUITING

Children's National Hospital, Washington D.C.

All Listed Sponsors
lead

Children's National Research Institute

OTHER

NCT04731974 - Acute Concussion and Melatonin | Biotech Hunter | Biotech Hunter